Status:
RECRUITING
Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Invasive Fungal Infections
Eligibility:
All Genders
18+ years
Brief Summary
Invasive filamentous fungal infections (aspergillosis, scedosporiosis, mucormycosis, fusarium wilt) are common and serious in immunocompromised subjects and particularly organ transplant patients. The...
Eligibility Criteria
Inclusion
- Adult patient ≥18 years old
- Heart transplant
- Invasive fungal infection with filamentous fungi during the period from January 1, 2008 to December 31, 2022
- Proven or probable infection with filamentous fungi according to EORTC/MSGERC criteria (20):
- Invasive aspergillosis
- Mucormycosis
- Fusarium wilt
- Scedosporiosis
- Other filamentous fungus infection
- Subject who has not expressed, after information, his opposition to the reuse of his data for the purposes of this research.
Exclusion
- Patient having expressed his opposition to participating in the study
- Patient not having a liver transplant
- Subject under guardianship, curatorship or safeguard of justice.
Key Trial Info
Start Date :
November 8 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 8 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06498310
Start Date
November 8 2023
End Date
November 8 2025
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France
Strasbourg, France, 67091